RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Chemical and Drug Induced Liver Injury
Accession: DOID:9007383
browse the term
Definition: A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.
Synonyms: exact_synonym: Chemically Induced Liver Toxicity; Drug Induced Acute Liver Injury; Drug Induced Liver Disease; Drug Induced Liver Injury; Drug-Induced Liver Diseases; Drug-Induced Liver Injuries; Toxic Hepatitis; chemically-induced liver toxicities; hepatotoxicity; toxic hepatitides
narrow_synonym: Drug-induced liver injury due to flucloxacillin
primary_id: MESH:D056486
alt_id: RDO:0007742
xref: EFO:0004228 ; EFO:0011052 ; NCI:C84427
G
AASS
aminoadipate-semialdehyde synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr14:59,950,123...59,993,457
Ensembl chr14:59,951,216...60,000,212
G
ABCB1
ATP binding cassette subfamily B member 1
susceptibility severity
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP::2677G>T/A(rs2032582)(human)
CTD RGD
PMID:20623750 PMID:26134275 PMID:27296832
RGD:11041130 RGD:14700895
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
G
ABCB11
ATP binding cassette subfamily B member 11
severity
ISO
DNA:SNP: :rs2287616(human)
RGD
PMID:27293027
RGD:14402413
NCBI chr36:13,742,895...13,835,312
Ensembl chr36:13,746,964...13,834,974
G
ABCC1
ATP binding cassette subfamily C member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18466103
NCBI chr 6:27,855,702...27,950,140
Ensembl chr 6:27,855,702...27,989,331
G
ABCC2
ATP binding cassette subfamily C member 2
susceptibility
ISO
DNA:polymorphism:promoter:-24C>T(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17241877 PMID:18381794 PMID:18466103 PMID:25196354
RGD:14700812 RGD:14700814
NCBI chr28:12,670,885...12,740,124
Ensembl chr28:12,670,885...12,740,740
G
ABI1
abl interactor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 2:6,941,752...7,059,466
Ensembl chr 2:6,941,900...7,057,684
G
ACE
angiotensin I converting enzyme
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:25143335
RGD:25671447
NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358
G
ACOX3
acyl-CoA oxidase 3, pristanoyl
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 3:60,154,012...60,205,696
Ensembl chr 3:60,153,775...60,203,554
G
ACSL1
acyl-CoA synthetase long chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr16:45,735,675...45,806,235
Ensembl chr16:45,735,703...45,804,970
G
ACTB
actin beta
ISO
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:22563491 PMID:25231249
RGD:9587759
NCBI chr 6:12,421,006...12,424,449
Ensembl chr 6:12,418,932...12,462,845
G
ACTN4
actinin alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:114,354,993...114,427,997
Ensembl chr 1:114,309,693...114,427,991
G
ACTR3
actin related protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr19:35,097,968...35,133,330
Ensembl chr19:35,098,639...35,169,724
G
ADA
adenosine deaminase
ISO
protein:increased expression:liver
RGD
PMID:21161045
RGD:5128859
NCBI chr24:32,083,786...32,119,810
Ensembl chr24:32,083,931...32,111,160
G
ADAM8
ADAM metallopeptidase domain 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24646716
NCBI chr28:40,853,665...40,865,604
Ensembl chr28:40,855,509...40,863,747
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20709802
NCBI chr34:19,398,310...19,410,519
Ensembl chr34:19,354,825...19,409,844
G
ADIPOR2
adiponectin receptor 2
severity
ISO
associated with obesity, LPS;mRNA:decreased expression:liver (rat)
RGD
PMID:23838384
RGD:8695926
NCBI chr27:43,739,269...43,840,116
Ensembl chr27:43,741,679...43,878,467
G
ADORA2B
adenosine A2b receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35292334
NCBI chr 5:39,884,375...39,908,214
G
AGT
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29499335
NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
G
AHR
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:decreased expression:liver (rat)
CTD RGD
PMID:21890736 PMID:28959666 PMID:34848246
RGD:401794432
NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444
G
AIFM1
apoptosis inducing factor mitochondria associated 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25743375
NCBI chr X:101,275,027...101,307,551
Ensembl chr X:101,275,017...101,307,367
G
AKR1A1
aldo-keto reductase family 1 member A1
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:29763686 PMID:32805337
RGD:27226688
NCBI chr15:14,792,398...14,808,805
Ensembl chr15:14,742,012...14,808,592
G
ALB
albumin
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18779383 PMID:22310181 PMID:27567545
RGD:14694844
NCBI chr13:62,133,747...62,169,349
Ensembl chr13:62,053,814...62,294,709
G
ALDH1L2
aldehyde dehydrogenase 1 family member L2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr10:33,310,523...33,365,677
Ensembl chr10:33,310,558...33,365,228
G
ALDH2
aldehyde dehydrogenase 2 family member
severity susceptibility
ISO
DNA:deletion:exon 3 (mouse) protein:increased expression:liver
RGD
PMID:21138988 PMID:24492981 PMID:30121625
RGD:14975148 RGD:15036810 RGD:7241599
NCBI chr26:9,319,109...9,361,021
G
ALDH9A1
aldehyde dehydrogenase 9 family member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr38:17,644,464...17,664,462
Ensembl chr38:17,644,459...17,663,886
G
ALDOB
aldolase, fructose-bisphosphate B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16115720
NCBI chr11:58,150,621...58,166,266
Ensembl chr11:58,150,967...58,176,319
G
AMBP
alpha-1-microglobulin/bikunin precursor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18779383
NCBI chr11:68,338,644...68,353,366
Ensembl chr11:68,338,389...68,351,994
G
ANXA2
annexin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr30:25,176,845...25,210,244
Ensembl chr30:25,115,842...25,218,281
G
ANXA6
annexin A6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:58,091,186...58,140,102
Ensembl chr 4:58,091,251...58,139,372
G
APOA1
apolipoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 5:16,740,071...16,742,081
Ensembl chr 5:16,740,130...16,741,943
G
APOE
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 1:110,525,717...110,528,534
Ensembl chr 1:110,525,722...110,528,440
G
APOH
apolipoprotein H
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:plasma:
CTD RGD
PMID:16099942 PMID:23288050
RGD:10054107
NCBI chr 9:14,082,648...14,095,186
Ensembl chr 9:14,082,541...14,095,185
G
ARG1
arginase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22872058
NCBI chr12:242,717...255,736
Ensembl chr12:242,714...255,305
G
ARNT
aryl hydrocarbon receptor nuclear translocator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20935161
Ensembl chr17:59,941,353...60,010,867 Ensembl chr17:59,941,353...60,010,867
G
ARNTL
aryl hydrocarbon receptor nuclear translocator like
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36602574
NCBI chr21:36,254,235...36,323,915
Ensembl chr21:36,290,070...36,323,622
G
ATG5
autophagy related 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22491424
NCBI chr12:63,565,859...63,692,383
Ensembl chr12:63,567,568...63,683,485
G
ATOH8
atonal bHLH transcription factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr17:39,255,725...39,280,022
G
ATP6V1D
ATPase H+ transporting V1 subunit D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 8:41,332,581...41,354,058
Ensembl chr 8:41,333,021...41,354,320
G
B9D2
B9 domain containing 2
treatment
ISO
RGD
PMID:27516150
RGD:14995464
NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
G
BAD
BCL2 associated agonist of cell death
treatment
ISO
RGD
PMID:25447754
RGD:10053709
NCBI chr18:52,781,335...52,791,789
Ensembl chr18:52,781,921...52,791,405
G
BAX
BCL2 associated X, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17906064
NCBI chr 1:107,423,388...107,426,464
Ensembl chr 1:107,422,424...107,426,464
G
BDH1
3-hydroxybutyrate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr33:30,407,021...30,422,735
Ensembl chr33:30,406,338...30,436,366
G
BDKRB2
bradykinin receptor B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30685357
NCBI chr 8:64,974,588...65,005,682
Ensembl chr 8:64,974,997...65,003,407
G
BLVRB
biliverdin reductase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:113,244,484...113,258,170
Ensembl chr 1:113,244,503...113,258,073
G
BPNT1
3'(2'), 5'-bisphosphate nucleotidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr38:14,834,642...14,857,242
Ensembl chr38:14,834,643...14,857,227
G
BRD4
bromodomain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr20:46,844,795...46,927,620
Ensembl chr20:46,891,514...46,927,608
G
BTD
biotinidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15469856
NCBI chr23:27,037,640...27,069,544
Ensembl chr23:27,037,921...27,069,456
G
C3
complement C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr20:53,566,226...53,598,365
Ensembl chr20:53,566,261...53,598,761
G
CA3
carbonic anhydrase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513 PMID:25231249
NCBI chr29:31,935,192...31,945,585
Ensembl chr29:31,935,172...31,980,579
G
CABP1
calcium binding protein 1
ISO
protein:increased expression:liver
RGD
PMID:21138988
RGD:7241599
NCBI chr26:16,492,484...16,523,265
G
CADPS2
calcium dependent secretion activator 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr14:60,109,253...60,465,982
Ensembl chr14:60,107,538...60,556,817
G
CANX
calnexin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:1,966,612...1,998,620
Ensembl chr11:1,927,888...1,998,604
G
CAP1
cyclase associated actin cytoskeleton regulatory protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr15:2,886,661...2,913,975
G
CASP8
caspase 8
treatment
ISO
RGD
PMID:25447754
RGD:10053709
NCBI chr37:10,362,071...10,402,108
Ensembl chr37:10,391,048...10,401,822
G
CAST
calpastatin
ISO
RGD
PMID:16871587
RGD:5683869
NCBI chr 3:12,920,514...13,031,974
Ensembl chr 3:12,922,453...13,031,959
G
CAT
catalase
ISO
protein:decreased expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:20623750 PMID:21138988 PMID:25231249
RGD:7241599
NCBI chr18:33,383,005...33,422,447
Ensembl chr18:33,383,005...33,422,447
G
CCDC80
coiled-coil domain containing 80
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr33:17,105,086...17,141,380
Ensembl chr33:17,105,086...17,139,896
G
CCL2
C-C motif chemokine ligand 2
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20623750 PMID:21813474 PMID:30663942
RGD:14995458 RGD:14995466
NCBI chr 9:39,008,187...39,009,932
G
CCR2
C-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr20:42,305,344...42,313,258
Ensembl chr20:42,307,580...42,308,698
G
CCR5
C-C motif chemokine receptor 5
susceptibility
ISO
acetaminophen
RGD
PMID:24770590
RGD:14401733
NCBI chr20:42,293,288...42,297,952
Ensembl chr20:42,294,996...42,297,952
G
CCT3
chaperonin containing TCP1 subunit 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 7:41,566,274...41,583,903
Ensembl chr 7:41,566,292...41,584,863
G
CCT5
chaperonin containing TCP1 subunit 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr34:4,035,851...4,049,131
Ensembl chr34:4,035,857...4,049,244
G
CDC25B
cell division cycle 25B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr24:17,552,206...17,561,791
Ensembl chr24:17,553,316...17,561,759
G
CDS1
CDP-diacylglycerol synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr32:8,349,033...8,416,451
Ensembl chr32:8,349,027...8,415,295
G
CELA1
chymotrypsin like elastase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr27:3,542,327...3,560,777
Ensembl chr27:3,542,309...3,560,777
G
CFAP20
cilia and flagella associated protein 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 2:58,445,932...58,459,437
Ensembl chr 2:58,445,927...58,459,779
G
CFH
complement factor H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr38:2,878,677...2,956,226
G
CHRM3
cholinergic receptor muscarinic 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20197374
NCBI chr 4:504,663...999,550
Ensembl chr 4:506,990...520,613
G
CLU
clusterin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr25:29,982,811...29,999,565
Ensembl chr25:29,982,811...29,999,563
G
COL14A1
collagen type XIV alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr13:19,033,423...19,249,189
Ensembl chr13:19,011,897...19,248,568
G
COL3A1
collagen type III alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16679477
NCBI chr36:30,488,250...30,526,367
Ensembl chr36:30,488,488...30,536,765
G
COMT
catechol-O-methyltransferase
ISO
protein:decreased expression:liver
RGD
PMID:21138988
RGD:7241599
NCBI chr26:29,359,930...29,381,854
Ensembl chr26:29,360,356...29,366,008
G
COQ9
coenzyme Q9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 2:58,964,221...58,977,589
Ensembl chr 2:58,964,318...58,977,573
G
CP
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr23:43,969,297...44,033,226
Ensembl chr23:43,969,435...44,030,369
G
CPB2
carboxypeptidase B2
ISO
mRNA,protein:increased expression,increased activity:liver,plasma
RGD
PMID:19386599
RGD:7243112
NCBI chr22:5,074,805...5,126,635
Ensembl chr22:5,074,816...5,126,170
G
CPS1
carbamoyl-phosphate synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr37:18,308,164...18,428,487
Ensembl chr37:18,143,986...18,427,697
G
CPT1A
carnitine palmitoyltransferase 1A
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr18:49,136,691...49,190,117
Ensembl chr18:49,136,691...49,190,117
G
CRP
C-reactive protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr38:22,396,787...22,398,180
Ensembl chr38:22,396,263...22,399,166
G
CSF3
colony stimulating factor 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20005281
NCBI chr 9:22,529,643...22,532,326
Ensembl chr 9:22,530,698...22,533,108
G
CTNNB1
catenin beta 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19679878
NCBI chr23:10,559,722...10,572,933
Ensembl chr23:10,559,718...10,572,927
G
CTSE
cathepsin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr38:2,368,711...2,380,554
Ensembl chr38:2,369,265...2,380,459
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11739529
NCBI chr32:598,406...599,925
Ensembl chr32:597,987...599,979
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33814510
NCBI chr30:37,793,277...37,799,535
Ensembl chr30:37,793,508...37,796,866
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28762043
NCBI chr30:37,818,400...37,824,192
Ensembl chr30:37,799,140...37,824,135
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33814510
NCBI chr17:30,273,281...30,278,554
Ensembl chr17:30,272,749...30,278,554
G
CYP27B1
cytochrome P450 family 27 subfamily B member 1
ISO
mRNA, protein:decreased expression:kidney (mouse)
RGD
PMID:26476181
RGD:25671412
NCBI chr10:1,825,224...1,830,845
Ensembl chr10:1,826,046...1,829,911
G
CYP2A13
cytochrome P450 family 2 subfamily A polypeptide 13
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23628428
NCBI chr 1:112,932,246...112,938,248
Ensembl chr 1:112,931,985...112,938,350
G
CYP2A7
cytochrome P450, family 2, subfamily A, polypeptide 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21741958
NCBI chr 1:112,900,508...112,906,745
Ensembl chr 1:112,900,403...112,907,076
G
CYP2B6
cytochrome P450 2B11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28762043 PMID:33814510
NCBI chr 1:112,817,561...112,833,294
Ensembl chr 1:112,816,502...112,833,293
G
CYP2C41
cytochrome P450 2C41
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14971821 PMID:21741958 PMID:25226513 PMID:28762043 PMID:33814510
G
CYP2D15
cytochrome P450 family 2 subfamily D member 15
ISO
DNA:hypermethylation:promoter
RGD
PMID:27490558
RGD:14700879
NCBI chr10:23,255,259...23,259,380
Ensembl chr10:23,255,249...23,259,298
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
treatment
ISO
associated with Endotoxemia DNA:hypermethylation:promoter CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12668988 PMID:16770646 PMID:21741958 PMID:25681370 PMID:27324775 PMID:27490558 PMID:27960551 PMID:28762043 PMID:29404441 More...
RGD:14700872 RGD:14700873 RGD:14700878 RGD:14700879 RGD:14700901
NCBI chr28:41,079,164...41,089,188
Ensembl chr28:41,035,025...41,122,754
G
CYP3A4
cytochrome P450, family 3, subfamily A, polypeptide 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28762043
NCBI chr 6:9,836,685...9,869,520
Ensembl chr 6:9,777,659...9,869,352
G
CYP8B1
cytochrome P450 family 8 subfamily B member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25448281
NCBI chr23:11,965,685...11,968,994
Ensembl chr23:11,967,341...11,968,846
G
DBT
dihydrolipoamide branched chain transacylase E2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 6:49,753,233...49,805,493
Ensembl chr 6:49,753,323...49,805,882
G
DDB1
damage specific DNA binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr18:55,064,720...55,097,623
Ensembl chr18:55,064,729...55,097,627
G
DGAT2
diacylglycerol O-acyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr21:22,833,659...22,850,300
Ensembl chr21:22,834,518...22,851,260
G
DHFR
dihydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19648163
NCBI chr 3:26,521,214...26,556,065
G
DHRS7
dehydrogenase/reductase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 8:35,251,988...35,269,880
Ensembl chr 8:35,251,975...35,269,869
G
DLA-DQB1
major histocompatibility complex, class II, DQ beta 1
susceptibility
ISO
DNA:polymorphism: :HLA-DQB1*05(human) CTD Direct Evidence: marker/mechanism DNA:polymorphism, haplotype
RGD CTD
PMID:21570397 PMID:25250564 PMID:26959717
RGD:11573514 RGD:36174016
NCBI chr12:2,305,307...2,307,711
G
DLA88
MHC class I DLA-88
ISO
ClinVar Annotator: match by term: Drug-induced liver injury due to flucloxacillin
ClinVar
PMID:11888582 PMID:11943262 PMID:12462283 PMID:15024131 PMID:15247624 PMID:15247625 PMID:18256392 PMID:19483685 More...
NCBI chr12:892,442...895,691
Ensembl chr12:892,388...1,021,690
G
DLAT
dihydrolipoamide S-acetyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:21,062,833...21,094,235
Ensembl chr 5:21,064,026...21,094,153
G
DNAJB9
DnaJ heat shock protein family (Hsp40) member B9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr14:48,879,963...48,885,616
Ensembl chr14:48,879,914...48,884,361
G
DNAJC12
DnaJ heat shock protein family (Hsp40) member C12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 4:19,096,656...19,147,722
Ensembl chr 4:19,096,656...19,147,655
G
DNAJC6
DnaJ heat shock protein family (Hsp40) member C6
ISO
protein:increased expression:liver (rat)
RGD
PMID:16538043
RGD:2301096
NCBI chr 5:45,055,294...45,119,595
Ensembl chr 5:44,884,283...45,120,203
G
DSC2
desmocollin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 7:58,369,316...58,402,028
Ensembl chr 7:58,322,959...58,457,978
G
ECHDC1
ethylmalonyl-CoA decarboxylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:66,012,245...66,073,008
Ensembl chr 1:66,012,782...66,073,000
G
ECHS1
enoyl-CoA hydratase, short chain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr28:40,939,856...40,947,694
Ensembl chr28:40,939,961...40,946,167
G
EDEM1
ER degradation enhancing alpha-mannosidase like protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr20:12,444,013...12,473,188
Ensembl chr20:12,452,730...12,472,069
G
EIF2AK1
eukaryotic translation initiation factor 2 alpha kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25411909
NCBI chr 6:11,447,225...11,478,611
Ensembl chr 6:11,447,081...11,478,658
G
EIF4EBP2
eukaryotic translation initiation factor 4E binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:21,339,037...21,364,224
Ensembl chr 4:21,339,045...21,358,072
G
ENDOG
endonuclease G
ISO
protein:decreased expression:mitochondrion:
RGD
PMID:22509279
RGD:9685364
NCBI chr 9:54,809,470...54,812,795
Ensembl chr 9:54,809,530...54,813,042
G
ENG
endoglin
ISO
protein:increased expression:liver (rat)
RGD
PMID:21146604
RGD:7257529
NCBI chr 9:55,558,246...55,590,081
Ensembl chr 9:55,558,305...55,589,064
G
ENO1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942 PMID:25231249
NCBI chr 5:62,300,805...62,314,508
Ensembl chr 5:62,300,808...62,304,093
G
ENPP2
ectonucleotide pyrophosphatase/phosphodiesterase 2
ISO
protein:increased activity:serum:
RGD
PMID:17850827
RGD:9685426
NCBI chr13:18,586,886...18,697,339
Ensembl chr13:18,587,129...18,697,324
G
EPHX1
epoxide hydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 7:38,964,319...39,004,902
Ensembl chr 7:38,964,338...38,999,238
G
ERLEC1
endoplasmic reticulum lectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr10:54,815,592...54,845,776
Ensembl chr10:54,815,638...54,845,080
G
ERN1
endoplasmic reticulum to nucleus signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30538632
NCBI chr 9:11,930,614...12,006,724
Ensembl chr 9:11,934,965...12,006,814
G
F13A1
coagulation factor XIII A chain
ISO
RGD
PMID:22019897
RGD:11041813
NCBI chr35:6,186,750...6,347,522
Ensembl chr35:6,187,235...6,349,773
G
F2RL3
F2R like thrombin or trypsin receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20974703
NCBI chr20:45,738,587...45,740,564
Ensembl chr20:45,738,587...45,740,473
G
F3
coagulation factor III, tissue factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22407844
NCBI chr 6:54,709,581...54,720,603
Ensembl chr 6:54,708,471...54,720,607
G
FADD
Fas associated via death domain
treatment
ISO
RGD
PMID:25447754 PMID:26062544
RGD:10053709 RGD:11341803
NCBI chr18:48,087,447...48,094,497
G
FADS1
fatty acid desaturase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr18:54,659,406...54,672,803
Ensembl chr18:54,659,406...54,670,623
G
FADS2
fatty acid desaturase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr18:54,552,105...54,581,553
Ensembl chr18:54,553,366...54,659,654
G
FAS
Fas cell surface death receptor
ISO
protein:increased expression:liver (rat)
RGD
PMID:16831245
RGD:8662853
NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
G
FASN
fatty acid synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 9:233,105...249,573
Ensembl chr 9:232,963...249,092
G
FCMR
Fc mu receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 7:6,046,270...6,064,063
Ensembl chr 7:6,048,814...6,064,013
G
FGA
fibrinogen alpha chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20974703
NCBI chr15:52,238,305...52,247,017
Ensembl chr15:52,236,198...52,246,975
G
FGF21
fibroblast growth factor 21
severity
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:29883717
RGD:15045603
NCBI chr 1:107,571,449...107,576,630
Ensembl chr 1:107,571,446...107,573,281
G
FLT1
fms related receptor tyrosine kinase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21135413
NCBI chr25:11,231,958...11,410,379
Ensembl chr25:11,231,737...11,407,621
G
FMO3
flavin containing dimethylaniline monoxygenase 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:24973094
NCBI chr 7:27,720,420...27,745,522
Ensembl chr 7:27,720,420...27,845,626
G
FTL
ferritin light chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:107,418,457...107,419,923
Ensembl chr 1:107,418,458...107,419,923
G
G6PC1
glucose-6-phosphatase catalytic subunit 1
ISO
mRNA:decreased expression:liver (mouse)
RGD
PMID:28189721
RGD:14695531
NCBI chr 9:20,132,973...20,143,642
Ensembl chr 9:20,132,978...20,143,642
G
G6PD
glucose-6-phosphate dehydrogenase
treatment
ISO
RGD
PMID:21864513
RGD:10449168
NCBI chr X:122,217,317...122,231,862
Ensembl chr X:122,205,683...122,231,678
G
GADD45A
growth arrest and DNA damage inducible alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 6:77,393,026...77,396,473
Ensembl chr 6:77,393,036...77,396,618
G
GANAB
glucosidase II alpha subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr18:54,004,296...54,019,148
Ensembl chr18:54,003,689...54,018,157
G
GC
GC vitamin D binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr13:60,795,305...60,828,038
Ensembl chr13:60,795,305...60,827,929
G
GCLC
glutamate-cysteine ligase catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17573345 PMID:19481141
RGD:10402383
NCBI chr12:20,999,815...21,047,779
Ensembl chr12:21,000,792...21,047,779
G
GCLM
glutamate-cysteine ligase modifier subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 6:55,204,602...55,244,217
G
GDA
guanine deaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:85,506,598...85,586,212
Ensembl chr 1:85,444,917...85,586,163
G
GDI1
GDP dissociation inhibitor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr X:122,141,633...122,146,724
Ensembl chr X:122,141,566...122,146,824
G
GFER
growth factor, augmenter of liver regeneration
treatment
ISO
RGD
PMID:15968720 PMID:22033404
RGD:9685722 RGD:9685727
NCBI chr 6:38,948,927...38,951,300
Ensembl chr 6:38,949,484...38,951,703
G
GGH
gamma-glutamyl hydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21219404
NCBI chr29:13,143,881...13,165,028
Ensembl chr29:13,134,232...13,165,028
G
GGT1
gamma-glutamyltransferase 1
ISO
RGD
PMID:10934156
RGD:14701049
NCBI chr26:28,301,455...28,315,029
G
GLUD1
glutamate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33483742
NCBI chr 4:34,629,046...34,662,711
G
GOT1
glutamic-oxaloacetic transaminase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr28:12,352,658...12,377,960
Ensembl chr28:12,352,659...12,414,579
G
GPD1
glycerol-3-phosphate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr27:4,614,878...4,622,013
Ensembl chr27:4,614,864...4,621,922
G
GPT
glutamic--pyruvic transaminase
treatment
ISO
protein:increased expression, activity:serum: CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:145039 PMID:19085960 PMID:19481104 PMID:21772750 PMID:27293452 PMID:28487901 More...
RGD:14975162 RGD:14975166 RGD:14975168 RGD:14975249
NCBI chr13:37,923,757...37,927,843
Ensembl chr13:37,924,422...37,926,156
G
GPT2
glutamic--pyruvic transaminase 2
ISO
protein:increased expression, activity:serum:
RGD
PMID:19085960
RGD:14975249
NCBI chr15:8,238,295...8,250,789
G
GRK4
G protein-coupled receptor kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 3:61,233,066...61,331,094
Ensembl chr 3:61,079,904...61,330,290
G
GSN
gelsolin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr11:74,248,227...74,268,129
Ensembl chr11:74,233,457...74,268,129
G
GSR
glutathione-disulfide reductase
treatment
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver
RGD CTD
PMID:23554813 PMID:24154663 PMID:25226513 PMID:28069987
RGD:10401878 RGD:7257532
NCBI chr16:33,633,949...33,680,411
Ensembl chr16:33,633,968...33,679,752
G
GSTA4
glutathione S-transferase alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr12:20,426,724...20,443,200
Ensembl chr12:20,426,726...20,443,200
G
GSTM3
glutathione S-transferase mu 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25743375
NCBI chr 6:42,187,869...42,191,274
Ensembl chr 6:42,187,967...42,191,273
G
GSTO1
glutathione S-transferase omega 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr28:16,569,421...16,579,239
Ensembl chr28:16,569,066...16,619,880
G
GSTP1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750 PMID:25226513
NCBI chr18:49,905,161...49,908,182
Ensembl chr18:49,905,161...49,908,182
G
H2AX
H2A.X variant histone
treatment
ISO
RGD
PMID:23265463
RGD:8693741
NCBI chr 5:14,765,625...14,766,590
Ensembl chr 5:14,766,126...14,766,557
G
HADHA
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr17:20,307,207...20,355,659
Ensembl chr17:20,307,226...20,355,508
G
HAMP
hepcidin antimicrobial peptide
ISO
mRNA:increased expression:hepatocyte
RGD
PMID:24373749
RGD:11041724
NCBI chr 1:117,305,531...117,306,587
Ensembl chr 1:117,305,411...117,306,619
G
HAO2
hydroxyacid oxidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr17:56,505,463...56,529,441
Ensembl chr17:56,505,506...56,528,954
G
HAVCR1
hepatitis A virus cellular receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 4:53,012,223...53,066,611
Ensembl chr 4:53,046,970...53,128,952 Ensembl chr 4:53,046,970...53,128,952
G
HLA-DRB1
MHC class II DLA DRB1 beta chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21570397
NCBI chr12:2,151,409...2,164,564
G
HMGB1
high mobility group box 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19783637 PMID:29091898
RGD:15090820
NCBI chr25:9,431,223...9,558,167
Ensembl chr25:9,431,218...9,558,165
G
HMOX1
heme oxygenase 1
treatment
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:18227147 PMID:22688006 PMID:22886620 PMID:29091898
RGD:10762620 RGD:15090820
NCBI chr10:28,744,404...28,751,544
Ensembl chr10:28,743,795...28,751,773
G
HPD
4-hydroxyphenylpyruvate dioxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942 PMID:22872058
NCBI chr26:7,430,891...7,440,643
Ensembl chr26:7,430,933...7,440,611
G
HPRT1
hypoxanthine phosphoribosyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr X:105,115,732...105,153,702
Ensembl chr X:105,115,732...105,153,702
G
HPX
hemopexin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr21:29,749,913...29,759,176
Ensembl chr21:29,719,589...29,759,046
G
HRH2
histamine receptor H2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22926047
NCBI chr 4:37,333,843...37,407,146
Ensembl chr 4:37,275,852...37,386,072
G
HSPA5
heat shock protein family A (Hsp70) member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 9:57,850,870...57,855,607
Ensembl chr 9:57,850,922...57,855,257
G
HSPA8
heat shock protein family A (Hsp70) member 8
ISO
protein:altered localization:liver (rat)
RGD
PMID:12376827
RGD:10059389
NCBI chr 5:11,292,219...11,296,851
Ensembl chr 5:11,292,262...11,296,797
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
RGD
PMID:29091898
RGD:15090820
NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
severity
ISO
RGD
PMID:31121248
RGD:14985250
NCBI chr 3:53,070,462...53,077,566
Ensembl chr 3:53,070,695...53,087,496
G
IDO2
indoleamine 2,3-dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32289347
NCBI chr16:25,319,035...25,375,085
Ensembl chr16:25,319,035...25,385,515
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12153990 PMID:21245496 PMID:30013034
RGD:14975100
NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
G
IGF1
insulin like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23639586 PMID:25226513
NCBI chr15:41,203,320...41,275,964
Ensembl chr15:41,202,518...41,275,794
G
IL11
interleukin 11
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11421492
NCBI chr 1:102,311,960...102,319,102
Ensembl chr 1:102,316,105...102,318,653
G
IL12B
interleukin 12B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36520315
NCBI chr 4:51,178,637...51,194,606
Ensembl chr 4:51,183,568...51,193,228
G
IL17A
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19633216 PMID:24949944
NCBI chr12:19,854,129...19,862,521
Ensembl chr12:19,854,129...19,862,513
G
IL18
interleukin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19164858
NCBI chr 5:20,972,742...20,995,327
Ensembl chr 5:20,972,871...20,995,348
G
IL1A
interleukin 1 alpha
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8218930
NCBI chr17:36,969,581...36,979,445
Ensembl chr17:36,970,573...36,979,435
G
IL1B
interleukin 1 beta
treatment
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:19164858 PMID:23102243 PMID:28138970 PMID:29091898 PMID:29278859 PMID:31077717 PMID:31342809 More...
RGD:13793380 RGD:14975281 RGD:15036799 RGD:15090820 RGD:7204421
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
IL1R2
interleukin 1 receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr10:40,967,532...41,003,659
Ensembl chr10:40,896,669...41,034,113
G
IL22
interleukin 22
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15122762 PMID:16212920 PMID:23375450
NCBI chr10:10,487,367...10,492,238
Ensembl chr10:10,487,262...10,492,371
G
IL4
interleukin 4
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:21094227 PMID:21735453 PMID:22107450
NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
G
IL6
interleukin 6
treatment
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:7532385 PMID:15763341 PMID:29091898
RGD:15090820
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
IMMT
inner membrane mitochondrial protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr17:38,927,508...38,964,522
Ensembl chr17:38,927,531...38,967,004
G
IRAK1
interleukin 1 receptor associated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr X:121,853,340...121,862,582
Ensembl chr X:121,819,432...121,862,576
G
ITPR1
inositol 1,4,5-trisphosphate receptor type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr20:12,746,171...13,065,256
Ensembl chr20:12,747,315...13,064,198
G
JUND
JunD proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30515189
NCBI chr20:44,737,021...44,738,932
Ensembl chr20:44,736,832...44,763,020
G
KEAP1
kelch like ECH associated protein 1
ISO
RGD
PMID:18417483
RGD:6893370
NCBI chr20:50,651,070...50,661,178
Ensembl chr20:50,650,711...50,658,496
G
KITLG
KIT ligand
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12594235
NCBI chr15:29,591,068...29,671,985
Ensembl chr15:29,591,170...29,671,974
G
KNG1
kininogen 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20362651 PMID:30685357
NCBI chr34:19,288,629...19,318,096
Ensembl chr34:19,287,109...19,318,081
G
KRT18
keratin 18
ISO
mRNA, protein:increased expression:liver (mouse) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17340120 PMID:19783637 PMID:33483742
RGD:18337498
NCBI chr27:2,189,269...2,193,368
Ensembl chr27:2,189,269...2,193,368
G
KRT8
keratin 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr27:2,221,608...2,229,343
G
LAP3
leucine aminopeptidase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 3:62,898,626...62,924,738
Ensembl chr 3:62,898,699...62,924,727
G
LBP
lipopolysaccharide binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr24:26,810,369...26,833,515
Ensembl chr24:26,809,843...26,833,434
G
LCAT
lecithin-cholesterol acyltransferase
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr 5:81,556,047...81,559,313
G
LCN2
lipocalin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20362651 PMID:20623750
NCBI chr 9:55,328,118...55,342,535
Ensembl chr 9:55,328,133...55,332,038
G
LDLR
low density lipoprotein receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36108984
NCBI chr20:50,115,175...50,152,443
Ensembl chr20:50,048,736...50,152,355
G
LGALS3
galectin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22461450
NCBI chr 8:30,977,438...30,994,711
Ensembl chr 8:30,983,633...30,994,705
G
LIPC
lipase C, hepatic type
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr30:23,432,460...23,584,037
Ensembl chr30:23,432,493...23,584,037
G
LOC100855540
hemoglobin subunit alpha-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 6:40,324,378...40,325,427
G
LOC100855552
creatine kinase B-type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 8:71,284,104...71,287,379
G
LOC477072
serotransferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr23:30,658,250...30,683,816
Ensembl chr23:30,595,704...30,683,845
G
LOC479912
glutathione S-transferase Mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 6:42,201,697...42,207,886
G
LOC482182
sulfotransferase 1E1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr13:59,323,430...59,343,745
G
LOC608697
2-hydroxyacyl-CoA lyase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr23:27,069,676...27,188,247
G
LOC610636
tubulin alpha-1B chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr37:25,811,491...25,818,838
G
LOC612036
solute carrier family 22 member 20-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr18:51,925,890...51,939,184
G
LPL
lipoprotein lipase
treatment
ISO
RGD
PMID:27071702
RGD:13794380
NCBI chr25:37,078,306...37,102,729
Ensembl chr25:37,079,756...37,102,700
G
LRAT
lecithin retinol acyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr15:52,399,773...52,409,590
Ensembl chr15:52,399,544...52,406,176
G
LTB4R
leukotriene B4 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28487374
NCBI chr 8:4,282,924...4,286,869
Ensembl chr 8:4,285,323...4,286,534
G
LTF
lactotransferrin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16141546
NCBI chr20:42,231,994...42,263,202
Ensembl chr20:42,231,994...42,263,202
G
MAP1LC3B
microtubule associated protein 1 light chain 3 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 5:65,669,553...65,683,445
G
MAP3K5
mitogen-activated protein kinase kinase kinase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18700144
NCBI chr 1:29,107,813...29,306,437
Ensembl chr 1:29,108,591...29,306,503
G
MAT1A
methionine adenosyltransferase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:29,450,857...29,467,251
Ensembl chr 4:29,452,601...29,466,929
G
MCCC1
methylcrotonyl-CoA carboxylase subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr34:16,022,493...16,084,346
Ensembl chr34:16,022,499...16,084,387
G
MDH1
malate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr10:63,316,818...63,334,556
Ensembl chr10:63,316,831...63,361,735
G
ME1
malic enzyme 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr12:43,623,413...43,793,590
Ensembl chr12:43,624,945...43,828,775
G
MED1
mediator complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16109766
NCBI chr 9:22,989,257...23,019,350
Ensembl chr 9:22,989,301...23,019,349
G
MIR1-1
microRNA mir-1-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30125006
NCBI chr24:46,481,078...46,481,136
Ensembl chr24:46,481,078...46,481,136
G
MIR103-1
microRNA mir-103-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 4:43,182,876...43,182,937
Ensembl chr 4:43,182,871...43,182,942
G
MIR106B
microRNA mir-106b
ISO
miRNA:decreased expression:liver (rat)
RGD
PMID:29554950
RGD:15042854
NCBI chr 6:9,498,558...9,498,616
Ensembl chr 6:9,498,558...9,498,616
G
MIR107
microRNA mir-107
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr28:4,484,653...4,484,710
Ensembl chr28:4,484,646...4,484,718
G
MIR10A
microRNA mir-10a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 9:24,842,171...24,842,233
Ensembl chr 9:24,842,145...24,842,248
G
MIR10B
microRNA mir-10b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr36:19,958,913...19,959,013
Ensembl chr36:19,958,913...19,959,013
G
MIR122
microRNA mir-122
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22045675 PMID:22363424 PMID:25359176 PMID:25527335 PMID:26489516 PMID:28545106 PMID:28844483 PMID:33483742 More...
NCBI chr 1:17,593,858...17,593,915
Ensembl chr 1:17,593,837...17,593,929
G
MIR1249
microRNA mir-1249
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr10:20,818,801...20,818,939
Ensembl chr10:20,818,801...20,818,939
G
MIR125B-1
microRNA mir-125b-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 5:12,097,672...12,097,732
Ensembl chr 5:12,097,658...12,097,745
G
MIR125B-2
microRNA mir-125b-2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr31:13,304,980...13,305,040
Ensembl chr31:13,304,964...13,305,052
G
MIR1306
microRNA mir-1306
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr26:29,255,671...29,255,728
Ensembl chr26:29,255,656...29,255,735
G
MIR1307
microRNA mir-1307
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr28:15,765,927...15,765,986
Ensembl chr28:15,765,918...15,765,997
G
MIR130A
microRNA mir-130a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr18:38,543,618...38,543,679
Ensembl chr18:38,543,618...38,543,681
G
MIR132
microRNA mir-132
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 9:46,153,531...46,153,590
Ensembl chr 9:46,153,511...46,153,611
G
MIR142
microRNA mir-142
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 9:32,977,393...32,977,455
Ensembl chr 9:32,977,382...32,977,468
G
MIR143
microRNA mir-143
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30125006
NCBI chr 4:59,534,535...59,534,589
Ensembl chr 4:59,534,535...59,534,594
G
MIR148A
microRNA mir-148a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr14:39,301,847...39,301,906
Ensembl chr14:39,301,843...39,301,920
G
MIR150
microRNA mir-150
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 1:106,998,756...106,998,812
Ensembl chr 1:106,998,756...106,998,812
G
MIR152
microRNA mir-152
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 9:24,335,161...24,335,219
Ensembl chr 9:24,335,146...24,335,225
G
MIR155
microRNA mir-155
treatment
ISO
RGD
PMID:26867493 PMID:27673475 PMID:29420849
RGD:21409750 RGD:25671463 RGD:25671474
NCBI chr31:21,078,768...21,078,828
Ensembl chr31:21,078,758...21,078,833
G
MIR17
microRNA mir-17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr22:42,478,013...42,478,071
Ensembl chr22:42,478,000...42,478,083
G
MIR181C
microRNA mir-181c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr20:48,593,343...48,593,403
Ensembl chr20:48,593,325...48,593,421
G
MIR188
microRNA mir-188
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:42,775,058...42,775,143
Ensembl chr X:42,775,058...42,775,143
G
MIR18A
microRNA mir-18a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr22:42,478,138...42,478,229
Ensembl chr22:42,478,138...42,478,229
G
MIR191
microRNA mir-191
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr20:40,144,135...40,144,198
Ensembl chr20:40,144,121...40,144,210
G
MIR192
microRNA mir-192
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22045675 PMID:25359176 PMID:28483554 PMID:28545106
NCBI chr18:52,281,129...52,281,193
Ensembl chr18:52,281,129...52,281,193
G
MIR193A
microRNA mir-193a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 9:41,316,481...41,316,536
Ensembl chr 9:41,316,474...41,316,542
G
MIR193B
microRNA mir-193b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 6:28,878,050...28,878,108
Ensembl chr 6:28,878,050...28,878,108
G
MIR194
microRNA mir-194
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28844483
NCBI chr38:14,895,401...14,895,458
Ensembl chr38:14,895,401...14,895,458
G
MIR19A
microRNA mir-19a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr22:42,478,298...42,478,355
Ensembl chr22:42,478,285...42,478,366
G
MIR200C
microRNA mir-200c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr27:38,082,097...38,082,159
Ensembl chr27:38,082,091...38,082,169
G
MIR203
microRNA mir-203
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:32659284
NCBI chr 8:71,774,247...71,774,340
Ensembl chr 8:71,774,247...71,774,340
G
MIR21
microRNA mir-21
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 9:34,340,550...34,340,609
Ensembl chr 9:34,340,533...34,340,624
G
MIR217
microRNA mir-217
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr10:56,754,566...56,754,647
Ensembl chr10:56,754,566...56,754,647
G
MIR218-1
microRNA mir-218-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424 PMID:30125006
NCBI chr 3:89,044,709...89,044,772
Ensembl chr 3:89,044,699...89,044,782
G
MIR22
microRNA mir-22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr 9:45,852,534...45,852,593
Ensembl chr 9:45,852,517...45,852,609
G
MIR221
microRNA mir-221
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:39,523,890...39,523,951
Ensembl chr X:39,523,885...39,523,954
G
MIR222
microRNA mir-222
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:39,524,519...39,524,608
Ensembl chr X:39,524,519...39,524,608
G
MIR223
microRNA mir-223
ISO
RNA:increased expression:serum,liver
RGD
PMID:28646120
RGD:21408574
NCBI chr X:50,838,131...50,838,233
Ensembl chr X:50,838,131...50,838,233
G
MIR23A
microRNA mir-23a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr20:48,620,335...48,620,386
Ensembl chr20:48,620,323...48,620,397
G
MIR23B
microRNA mir-23b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 1:71,678,353...71,678,406
Ensembl chr 1:71,678,346...71,678,416
G
MIR27B
microRNA mir-27b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr 1:71,678,117...71,678,179
Ensembl chr 1:71,678,105...71,678,191
G
MIR29B-2
microRNA mir-29b-2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 7:6,651,878...6,651,943
Ensembl chr 7:6,651,866...6,651,955
G
MIR29C-2
microRNA mir-29c-2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106 PMID:30515189
NCBI chr 7:6,651,339...6,651,396
G
MIR301A
microRNA mir-301a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 9:33,724,572...33,724,655
Ensembl chr 9:33,724,571...33,724,655
G
MIR30A
microRNA mir-30a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424 PMID:25359176 PMID:28545106
NCBI chr12:33,783,894...33,783,956
Ensembl chr12:33,783,891...33,783,961
G
MIR30B
microRNA mir-30b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr13:30,906,038...30,906,097
Ensembl chr13:30,906,038...30,906,097
G
MIR30C-1
microRNA mir-30c-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr15:2,280,050...2,280,110
Ensembl chr15:2,280,039...2,280,121
G
MIR335
microRNA mir-335
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr14:6,444,861...6,444,918
Ensembl chr14:6,444,847...6,444,932
G
MIR33B
microRNA mir-33b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 5:41,685,165...41,685,258
Ensembl chr 5:41,685,165...41,685,258
G
MIR342
microRNA mir-342
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 8:68,424,656...68,424,718
G
MIR345
microRNA mir-345
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 8:68,592,447...68,592,506
G
MIR34A
microRNA mir-34a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 5:62,485,832...62,485,897
Ensembl chr 5:62,485,832...62,485,897
G
MIR34C
microRNA mir-34c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 5:21,558,106...21,558,160
G
MIR361
microRNA mir-361
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:66,698,698...66,698,760
Ensembl chr X:66,698,698...66,698,760
G
MIR367
microRNA mir-367
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr32:32,428,905...32,428,972
Ensembl chr32:32,428,905...32,428,972
G
MIR378
microRNA mir-378
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 4:59,276,347...59,276,406
Ensembl chr 4:59,276,336...59,276,417
G
MIR410
microRNA mir-410
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 8:69,294,377...69,294,432
G
MIR421
microRNA mir-421
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:57,550,055...57,550,110
Ensembl chr X:57,550,039...57,550,123
G
MIR423A
microRNA mir-423a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 9:44,155,913...44,155,971
G
MIR452
microRNA mir-452
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:119,926,379...119,926,463
Ensembl chr X:119,926,379...119,926,463
G
MIR455
microRNA mir-455
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:68,461,911...68,461,968
Ensembl chr11:68,461,896...68,461,983
G
MIR497
microRNA mir-497
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 5:32,045,759...32,045,825
Ensembl chr 5:32,045,759...32,045,825
G
MIR505
microRNA mir-505
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:109,866,448...109,866,523
Ensembl chr X:109,866,448...109,866,523
G
MIR532
microRNA mir-532
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:42,774,680...42,774,738
Ensembl chr X:42,774,680...42,774,738
G
MIR592
microRNA mir-592
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424 PMID:28545106
NCBI chr14:9,182,237...9,182,331
Ensembl chr14:9,182,237...9,182,331
G
MIR660
microRNA mir-660
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:42,783,965...42,784,023
Ensembl chr X:42,783,965...42,784,023
G
MIR885
microRNA mir-885
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr20:7,968,529...7,968,602
Ensembl chr20:7,968,529...7,968,602
G
MIR93
microRNA mir-93
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 6:9,498,780...9,498,840
G
MIR99A-1
microRNA mir-99a-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr31:13,258,782...13,258,840
Ensembl chr31:13,258,782...13,258,840
G
MIR99A-2
microRNA mir-99a-2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 5:12,047,369...12,047,425
Ensembl chr 5:12,047,369...12,047,425
G
MIRLET7C
microRNA let-7c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr31:13,259,522...13,259,588
Ensembl chr31:13,259,502...13,259,609
G
MIRLET7D
microRNA let-7d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 1:97,902,012...97,902,136
Ensembl chr 1:97,902,012...97,902,136
G
MIRLET7G
microRNA let-7g
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr20:37,501,074...37,501,152
Ensembl chr20:37,501,054...37,501,160
G
MMP2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15763341
NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113
G
MMP9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22507835
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
G
MST1
macrophage stimulating 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr20:39,582,237...39,586,958
Ensembl chr20:39,582,282...39,586,908
G
MST1R
macrophage stimulating 1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22575169
NCBI chr20:39,386,970...39,400,780
Ensembl chr20:39,387,322...39,400,588
G
MT-ND6
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6
ISO
mRNA:decreased expression:blood
RGD
PMID:20130021
RGD:8657129
NCBI chr MT:13,582...14,109
Ensembl chr MT:13,582...14,109
G
MTHFR
methylenetetrahydrofolate reductase
treatment
ISO
associated with precursor lymphoblastic lymphoma/leukemia; DNA:SNP: :677C>T(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18551038 PMID:19648163 PMID:30545275
RGD:14696733
NCBI chr 2:84,445,526...84,457,435
Ensembl chr 2:84,380,919...84,536,818
G
MTPN
myotrophin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr16:12,316,487...12,369,148
Ensembl chr16:12,316,336...12,369,387
G
MYD88
MYD88 innate immune signal transduction adaptor
ameliorates
ISO
RGD
PMID:17615358
RGD:150521532
NCBI chr23:7,901,578...7,905,274
Ensembl chr23:7,901,250...7,904,534
G
NDUFS3
NADH:ubiquinone oxidoreductase core subunit S3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr18:42,069,402...42,075,843
Ensembl chr18:42,069,398...42,076,921
G
NECAB3
N-terminal EF-hand calcium binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30515189
NCBI chr24:22,895,149...22,904,689
Ensembl chr24:22,878,402...22,904,656
G
NFATC4
nuclear factor of activated T cells 4
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34192554
NCBI chr 8:4,337,098...4,346,409
Ensembl chr 8:4,336,450...4,346,100
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment
ISO
CTD Direct Evidence: therapeutic induced by methotrexate (CHEBI:44185), treated by ferulic acid (CHEBI:17620)
CTD RGD
PMID:18417483 PMID:22491424 PMID:22627062 PMID:24813929 PMID:26958860 PMID:29091898 PMID:30215777 PMID:31889292 PMID:31927046 PMID:31972209 PMID:32066295 More...
RGD:15090820 RGD:21201280 RGD:21201283 RGD:21201305 RGD:21201308 RGD:6893370
NCBI chr36:20,989,205...21,087,044
Ensembl chr36:20,989,360...21,012,524
G
NFKB1
nuclear factor kappa B subunit 1
treatment susceptibility
ISO
associated with tuberculosis ;DNA:SNPs,haplotypes: 3'utr,5'utr: (rs78872571,rs4647992) (human)
RGD
PMID:29091898 PMID:31490979
RGD:15090820 RGD:40902984
NCBI chr32:23,948,598...24,040,704
Ensembl chr32:23,942,954...24,040,703
G
NFXL1
nuclear transcription factor, X-box binding like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr13:43,743,271...43,814,899
Ensembl chr13:43,744,181...43,814,520
G
NME2
non-metastatic cells 2, protein (NM23B) expressed in
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 9:27,002,114...27,005,740
Ensembl chr 9:27,001,733...27,015,934
G
NOTCH1
notch receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30394310
NCBI chr 9:48,975,972...49,018,985
Ensembl chr 9:48,974,757...49,017,277
G
NOX4
NADPH oxidase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr21:10,615,153...10,782,927
Ensembl chr21:10,615,970...10,775,277
G
NQO1
NAD(P)H quinone dehydrogenase 1
treatment
ISO
RGD
PMID:28472605 PMID:28522909 PMID:29091898
RGD:13439737 RGD:13439739 RGD:15090820
NCBI chr 5:79,979,593...79,990,875
Ensembl chr 5:79,978,865...79,989,860
G
NR0B2
nuclear receptor subfamily 0 group B member 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29943110
NCBI chr 2:73,234,482...73,236,548
Ensembl chr 2:73,234,586...73,236,206
G
NR1D1
nuclear receptor subfamily 1 group D member 1
treatment
ISO
RGD
PMID:24497272
RGD:10448995
NCBI chr 9:22,461,556...22,469,243
Ensembl chr 9:22,461,705...22,469,053
G
NR1H3
nuclear receptor subfamily 1 group H member 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17256725
NCBI chr18:42,333,173...42,346,152
Ensembl chr18:42,333,202...42,341,236
G
NR1H4
nuclear receptor subfamily 1 group H member 4
severity treatment
ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:liver (rat) mRNA:decreased expression:liver (rat)
CTD RGD
PMID:12875239 PMID:20573685 PMID:22711662 PMID:28827769 PMID:29091898 PMID:30068870 More...
RGD:14701035 RGD:14701036 RGD:15042870 RGD:15045609 RGD:15090820
NCBI chr15:39,497,313...39,608,120
Ensembl chr15:39,536,290...39,608,116
G
NR1I2
nuclear receptor subfamily 1 group I member 2
susceptibility
ISO
CTD Direct Evidence: marker/mechanism|therapeutic associated with tuberculosis ;DNA:SNP,haplotypes:promoter: (rs3814055) (human)
CTD RGD
PMID:19797606 PMID:28058446 PMID:31490979
RGD:40902984
NCBI chr33:23,444,367...23,456,405
Ensembl chr33:23,432,690...23,455,347
G
NR1I3
nuclear receptor subfamily 1 group I member 3
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:14742670 PMID:25656644 PMID:28058446
NCBI chr38:21,252,874...21,257,951
Ensembl chr38:21,253,089...21,258,827
G
NR2F2
nuclear receptor subfamily 2 group F member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 3:44,135,143...44,148,836
Ensembl chr 3:44,136,463...44,148,524
G
NR5A2
nuclear receptor subfamily 5 group A member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29515023
NCBI chr 7:2,925,915...3,062,118
Ensembl chr 7:2,927,326...3,062,348
G
NREP
neuronal regeneration related protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 3:997,142...1,025,215
Ensembl chr 3:997,234...1,024,087
G
NTN1
netrin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35292334
NCBI chr 5:33,654,723...33,825,832
Ensembl chr 5:33,637,142...33,825,899
G
NUS1
NUS1 dehydrodolichyl diphosphate synthase subunit
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33812996
NCBI chr 1:57,866,760...57,895,505
Ensembl chr 1:57,866,879...57,893,077
G
OCIAD1
OCIA domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr13:44,608,474...44,634,665
Ensembl chr13:44,565,044...44,634,263
G
OGDH
oxoglutarate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
G
OR51E2
olfactory receptor family 51 subfamily E member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr21:27,078,888...27,081,746
Ensembl chr21:27,080,476...27,081,438
G
P4HB
prolyl 4-hydroxylase subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 9:427,827...436,880
Ensembl chr 9:427,830...436,064
G
PAH
phenylalanine hydroxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr15:41,590,253...41,670,156
Ensembl chr15:41,592,876...41,670,837
G
PAN2
poly(A) specific ribonuclease subunit PAN2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr10:621,286...636,899
Ensembl chr10:621,281...634,495
G
PANX1
pannexin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29246445
NCBI chr21:6,665,730...6,715,272
Ensembl chr21:6,668,269...6,715,858
G
PARK7
Parkinsonism associated deglycase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:61,576,219...61,592,325
Ensembl chr 5:61,576,069...61,592,303
G
PC
pyruvate carboxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr18:50,406,994...50,507,677
Ensembl chr18:50,412,272...50,507,669
G
PCOLCE
procollagen C-endopeptidase enhancer
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 6:9,085,145...9,090,447
Ensembl chr 6:9,085,145...9,090,146
G
PCYT1A
phosphate cytidylyltransferase 1A, choline
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr33:29,363,282...29,414,635
Ensembl chr33:29,358,452...29,430,424
G
PDK4
pyruvate dehydrogenase kinase 4
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:21182459 PMID:31809757
NCBI chr14:20,825,861...20,839,290
Ensembl chr14:20,827,831...20,839,256
G
PDLIM5
PDZ and LIM domain 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr32:17,294,023...17,505,212
Ensembl chr32:17,294,073...17,502,409
G
PEX11A
peroxisomal biogenesis factor 11 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 3:52,674,363...52,684,776
Ensembl chr 3:52,674,348...52,684,660
G
PGM1
phosphoglucomutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:46,444,433...46,577,621
Ensembl chr 5:46,515,295...46,577,622
G
PLAT
plasminogen activator, tissue type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22507835
NCBI chr16:23,469,590...23,496,013
G
PLG
plasminogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22507835
NCBI chr 1:49,497,229...49,535,260
Ensembl chr 1:49,497,229...49,535,260
G
PLS3
plastin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr X:88,308,817...88,399,682
Ensembl chr X:88,308,888...88,398,810
G
PNP
purine nucleoside phosphorylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr15:17,808,454...17,815,987
Ensembl chr15:17,808,461...17,815,676
G
PNRC1
proline rich nuclear receptor coactivator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr12:48,339,946...48,344,026
Ensembl chr12:48,339,346...48,415,732
G
POLG
DNA polymerase gamma, catalytic subunit
no_association susceptibility
ISO
DNA:missense mutations:cds:p.Q1236H, p.E1143G (33708G>T, 3428A>G) (human) DNA:missense mutation:cds:p.W748S, p.E1143G (2243G>C, 3428A>G) (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18208989 PMID:20138553 PMID:25065347 PMID:30255931
RGD:15039297 RGD:15039302
NCBI chr 3:52,357,062...52,373,768
Ensembl chr 3:52,357,068...52,421,544
G
POLR2G
RNA polymerase II subunit G
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr18:53,916,431...53,919,724
Ensembl chr18:53,916,435...53,919,549
G
PON1
paraoxonase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr14:20,565,620...20,600,774
Ensembl chr14:20,565,641...20,642,985
G
PPARA
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism LPS-induced acute liver damage
CTD RGD
PMID:21262334 PMID:24385052
RGD:5509941
NCBI chr10:19,934,020...20,006,096
Ensembl chr10:19,934,165...20,006,146
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:26599535
RGD:11554658
NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981
G
PPTC7
protein phosphatase targeting COQ7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr26:8,345,690...8,383,902
Ensembl chr26:8,349,453...8,383,617
G
PRKAA1
protein kinase AMP-activated catalytic subunit alpha 1
treatment
ISO
RGD
PMID:29091898
RGD:15090820
NCBI chr 4:68,579,061...68,614,548
Ensembl chr 4:68,579,037...68,611,841
G
PRKCD
protein kinase C delta
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30393195
NCBI chr20:36,723,491...36,751,982
Ensembl chr20:36,723,809...36,752,191
G
PRKDC
protein kinase, DNA-activated, catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21224054
NCBI chr29:24,904...243,926
Ensembl chr29:35,007...243,895
G
PTF1A
pancreas associated transcription factor 1a
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21182459
NCBI chr 2:10,069,594...10,071,360
Ensembl chr 2:10,069,581...10,071,336
G
PTGES2
prostaglandin E synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31444509
NCBI chr 9:55,343,424...55,349,349
Ensembl chr 9:55,343,424...55,348,959
G
PTGS2
prostaglandin-endoperoxide synthase 2
treatment
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:11743745 PMID:29091898
RGD:15090820
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
PUM1
pumilio RNA binding family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 2:69,907,655...70,044,055
Ensembl chr 2:69,907,735...70,042,680
G
PYGL
glycogen phosphorylase L
ISO
protein:increased expression:serum (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:25231249 PMID:25336395
RGD:21079733
NCBI chr 8:27,264,778...27,307,977
Ensembl chr 8:27,223,273...27,307,977
G
RASA1
RAS p21 protein activator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 3:21,068,182...21,177,288
Ensembl chr 3:21,054,930...21,176,757
G
RBP1
retinol binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr23:35,677,844...35,698,194
Ensembl chr23:35,679,176...35,698,363
G
RDH13
retinol dehydrogenase 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27865848
NCBI chr 1:102,539,363...102,552,749
Ensembl chr 1:102,539,124...102,554,027
G
REEP5
receptor accessory protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 3:6,733...25,840
Ensembl chr 3:8,236...25,824
G
RGN
regucalcin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr X:40,697,292...40,715,491
Ensembl chr X:40,698,768...40,715,490
G
RIPK3
receptor interacting serine/threonine kinase 3
ISO
CTD Direct Evidence: therapeutic protein:increased expression:liver (mouse)
CTD RGD
PMID:26769846 PMID:28205631
RGD:127229945
NCBI chr 8:4,304,167...4,309,514
Ensembl chr 8:4,305,250...4,309,325
G
S100A11
S100 calcium binding protein A11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr17:61,020,136...61,050,513
G
SCARB1
scavenger receptor class B member 1
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr26:5,035,797...5,122,383
Ensembl chr26:5,049,407...5,121,468
G
SELENBP1
selenium binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr17:60,410,727...60,418,770
Ensembl chr17:60,410,734...60,418,704
G
SEMA3A
semaphorin 3A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33290778
NCBI chr18:23,411,607...23,866,631
Ensembl chr18:23,414,576...23,867,098
G
SEMA4A
semaphorin 4A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33290778
NCBI chr 7:41,670,814...41,695,349
Ensembl chr 7:41,672,120...41,692,460
G
SENP2
SUMO specific peptidase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29535048
NCBI chr34:18,325,373...18,357,152
Ensembl chr34:18,325,553...18,356,192
G
SERPINA1
serpin family A member 1
susceptibility
ISO
protein:decreased expression:plasma DNA:missense mutation:cds:p.E264V(human)
RGD
PMID:11140575 PMID:20170533
RGD:14695048 RGD:1643168
NCBI chr 8:63,388,498...63,400,377
Ensembl chr 8:63,376,945...63,398,435
G
SERPINA6
serpin family A member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 8:63,323,896...63,341,829
Ensembl chr 8:63,323,933...63,453,708
G
SERPINE1
serpin family E member 1
treatment
ISO
associated with precursor lymphoblastic lymphoma/leukemia;DNA:SNPs: :DNA:SNPs: :677C>T, 1298A>C(human)
RGD
PMID:23183238
RGD:14696750
NCBI chr 6:8,719,547...8,727,160
Ensembl chr 6:8,720,825...8,726,301
G
SERPING1
serpin family G member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr18:38,570,354...38,580,751
Ensembl chr18:38,570,607...38,581,665
G
SESN2
sestrin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:28209544
NCBI chr 2:72,151,464...72,168,861
Ensembl chr 2:72,151,868...72,168,492
G
SGF29
SAGA complex associated factor 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 6:18,179,656...18,209,206
Ensembl chr 6:18,172,289...18,209,160
G
SHC1
SHC adaptor protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249 PMID:32659284
NCBI chr 7:42,501,829...42,509,613
Ensembl chr 7:42,500,185...42,508,276
G
SLC10A1
solute carrier family 10 member 1
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28827769
RGD:15045609
NCBI chr 8:43,521,291...43,546,426
Ensembl chr 8:43,521,747...43,546,274
G
SLC10A7
solute carrier family 10 member 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr15:44,718,085...44,957,787
Ensembl chr15:44,720,629...44,957,495
G
SLC13A4
solute carrier family 13 member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr16:12,539,369...12,581,155
Ensembl chr16:12,540,263...12,579,949
G
SLC22A8
solute carrier family 22 member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr18:53,709,592...53,728,595
Ensembl chr18:53,709,591...53,728,578
G
SLC25A29
solute carrier family 25 member 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 8:68,578,323...68,585,867
Ensembl chr 8:68,566,924...68,585,545
G
SLC7A5
solute carrier family 7 member 5
treatment
ISO
RGD
PMID:9200186
RGD:151357001
NCBI chr 5:65,313,105...65,343,858
Ensembl chr 5:65,313,105...65,343,858
G
SLPI
secretory leukocyte peptidase inhibitor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr24:32,566,030...32,568,406
Ensembl chr24:32,566,026...32,568,420
G
SNX18
sorting nexin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr 4:60,803,245...60,945,317
Ensembl chr 4:60,835,783...60,945,828
G
SOD1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750 PMID:27349771
NCBI chr31:26,540,291...26,544,212
Ensembl chr31:26,486,274...26,662,815
G
SOD2
superoxide dismutase 2
treatment susceptibility severity
ISO
associated with acute lymphoblastic leukemia;DNA:SNP: :(rs4880)(human) CTD Direct Evidence: marker/mechanism DNA:SNP:cds:p.Val16Ala(human)
RGD CTD
PMID:19332662 PMID:19647030 PMID:20578157 PMID:25226513 PMID:27019981
RGD:11060605 RGD:26923957 RGD:26923959 RGD:26923961
NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
G
SOD3
superoxide dismutase 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11529661
NCBI chr 3:85,382,698...85,387,144
Ensembl chr 3:85,382,484...85,387,455
G
SORD
sorbitol dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12763371
NCBI chr30:11,467,259...11,501,166
Ensembl chr30:11,467,253...11,500,641
G
SORL1
sortilin related receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 5:12,493,750...12,650,530
Ensembl chr 5:12,431,377...12,650,784
G
SPP1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr32:11,354,070...11,362,325
Ensembl chr32:11,353,953...11,362,069
G
SRP72
signal recognition particle 72
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr13:48,688,295...48,717,826
Ensembl chr13:48,688,295...48,717,824
G
STAT4
signal transducer and activator of transcription 4
severity
ISO
mRNA:increased expression:liver, macrophage (mouse) protein:increased phosphorylation:liver, inflammatory cell (mouse)
RGD
PMID:23876342 PMID:24731448
RGD:25671417 RGD:25671422
NCBI chr37:1,566,563...1,685,378
Ensembl chr37:1,566,585...1,829,894
G
STING1
stimulator of interferon response cGAMP interactor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36520315
NCBI chr 2:34,783,947...34,792,204
Ensembl chr 2:34,784,232...34,789,072
G
SULT1C3
sulfotransferase family 1C member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr10:35,610,282...35,644,315
Ensembl chr10:35,610,989...35,644,557
G
SULT2B1
sulfotransferase family 2B member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27052460
NCBI chr 1:107,705,568...107,721,160
Ensembl chr 1:107,705,576...107,720,876
G
SUOX
sulfite oxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr10:327,656...331,826
Ensembl chr10:327,671...331,825
G
TAGLN2
transgelin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr38:22,224,223...22,230,292
Ensembl chr38:22,225,133...22,229,766
G
TALDO1
transaldolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19436114
NCBI chr18:25,764,138...25,772,043
G
TBXA2R
thromboxane A2 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22206755
NCBI chr20:55,819,866...55,829,395
Ensembl chr20:55,824,410...55,828,980
G
TCTN1
tectonic family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr26:8,411,429...8,444,640
Ensembl chr26:8,407,105...8,437,027
G
TGFBR1
transforming growth factor beta receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28560358
NCBI chr11:56,191,383...56,223,042
Ensembl chr11:56,161,772...56,218,594
G
THBS1
thrombospondin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35357534
NCBI chr30:6,770,212...6,786,875
Ensembl chr30:6,769,470...6,784,915
G
THPO
thrombopoietin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33122006
NCBI chr34:17,245,006...17,255,250
Ensembl chr34:17,247,731...17,253,033
G
TLR4
toll like receptor 4
disease_progression
ISO
RGD
PMID:17504260
RGD:14697733
NCBI chr11:71,356,390...71,367,166
Ensembl chr11:71,356,390...71,367,165
G
TLR5
toll like receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30508503
NCBI chr38:23,700,323...23,705,628
Ensembl chr38:23,702,033...23,705,314
G
TLR9
toll like receptor 9
severity treatment
ISO
protein:increased expression: blood, neutrophil (human)
RGD
PMID:19164858 PMID:23509352 PMID:26457748
RGD:18337465 RGD:18337473 RGD:18337476
NCBI chr20:37,529,322...37,547,117
Ensembl chr20:37,542,340...37,547,114 Ensembl chr20:37,542,340...37,547,114
G
TMED7
transmembrane p24 trafficking protein 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr11:5,342,265...5,356,828
Ensembl chr11:5,342,265...5,356,828
G
TMEM117
transmembrane protein 117
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr27:9,782,805...10,246,635
Ensembl chr27:9,782,805...10,235,028
G
TMEM164
transmembrane protein 164
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr X:83,219,530...83,384,900
Ensembl chr X:83,219,505...83,381,564
G
TMEM38B
transmembrane protein 38B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr11:61,511,756...61,561,987
Ensembl chr11:61,511,750...61,560,556
G
TNF
tumor necrosis factor
treatment severity
ISO
protein:increased expression:serum (rat) CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:7532385 PMID:9309314 PMID:9696492 PMID:10801287 PMID:10801288 PMID:11124822 PMID:14686721 PMID:15830285 PMID:17070847 PMID:17709330 PMID:19638433 PMID:20623750 PMID:21984482 PMID:29091898 PMID:31077717 PMID:31342809 PMID:37866487 More...
RGD:10450531 RGD:14696804 RGD:14975281 RGD:14995429 RGD:14995432 RGD:14995435 RGD:14995437 RGD:14995485 RGD:15036799 RGD:15090820
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
TRPM2
transient receptor potential cation channel subfamily M member 2
ISO
RGD
PMID:24569808
RGD:9999438
NCBI chr31:38,201,075...38,224,076
G
TTR
transthyretin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 7:57,940,354...57,947,084
Ensembl chr 7:57,914,381...57,947,058
G
TUBB4B
tubulin beta 4B class IVb
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 9:48,432,114...48,434,626
Ensembl chr 9:48,427,766...48,571,640
G
UBA5
ubiquitin like modifier activating enzyme 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr23:29,645,755...29,658,587
Ensembl chr23:29,645,966...29,659,019
G
UNC93B1
unc-93 homolog B1, TLR signaling regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr18:49,826,044...49,835,417
Ensembl chr18:49,826,026...49,882,461
G
USP5
ubiquitin specific peptidase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr27:38,158,850...38,172,689
Ensembl chr27:38,158,834...38,172,071
G
VEGFA
vascular endothelial growth factor A
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17784864 PMID:25231249
RGD:15003197
NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
G
VIM
vimentin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 2:19,671,316...19,679,367
Ensembl chr 2:19,671,316...19,679,466
G
VWF
von Willebrand factor
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver:
CTD RGD
PMID:7531171 PMID:28527913
RGD:11079232
NCBI chr27:38,834,812...38,972,614
Ensembl chr27:38,833,837...39,320,142
G
WASL
WASP like actin nucleation promoting factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr14:11,828,298...11,901,190
Ensembl chr14:11,828,687...11,899,788
G
XRCC1
X-ray repair cross complementing 1
susceptibility
ISO
DNA:haploinsufficiency: : (mouse)
RGD
PMID:21737425
RGD:15036796
NCBI chr 1:111,548,719...111,571,816
Ensembl chr 1:111,548,719...111,571,816
G
XYLB
xylulokinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr23:8,123,041...8,171,803
Ensembl chr23:8,122,197...8,170,447
G
ZDHHC23
zinc finger DHHC-type palmitoyltransferase 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr33:18,215,822...18,227,626
Ensembl chr33:18,215,678...18,223,268
G
ABCC2
ATP binding cassette subfamily C member 2
susceptibility no_association
ISO
DNA:polymorphisms,haplotype:promoter:g.-1774delG,g.-1549G>A(human) DNA:SNPs:multiple:
RGD
PMID:17502832 PMID:22178260
RGD:14700816 RGD:14700817
NCBI chr28:12,670,885...12,740,124
Ensembl chr28:12,670,885...12,740,740
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
ISO
DNA:hypermethylation:promoter
RGD
PMID:23619520
RGD:14700910
NCBI chr28:41,079,164...41,089,188
Ensembl chr28:41,035,025...41,122,754
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:16140414
RGD:2316848
NCBI chr 3:30,970,037...30,988,987
Ensembl chr 3:30,970,037...30,990,294
G
LPAR1
lysophosphatidic acid receptor 1
ISO
protein:increased expression:liver (mouse)
RGD
PMID:12201952
RGD:10054288
NCBI chr11:65,690,806...65,822,166
Ensembl chr11:65,692,973...65,822,312
G
MIR22
microRNA mir-22
ISO
in male; RNA:increased expression:liver:
RGD
PMID:21750200
RGD:14700876
NCBI chr 9:45,852,534...45,852,593
Ensembl chr 9:45,852,517...45,852,609
G
GPT
glutamic--pyruvic transaminase
treatment
ISO
RGD
PMID:28921207
RGD:14975164
NCBI chr13:37,923,757...37,927,843
Ensembl chr13:37,924,422...37,926,156
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all